TrialClinical and translational science2025

A First-In-Human Phase 1 Study to Evaluate the Safety and Tolerability of LEM-S401, a Novel siRNA-DegradaBALL Drug Targeting CTGF in Healthy Adults.

Ha-Yeon Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.